The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease
This article has 18 authors:Reviewed by ScreenIT
-
Observational study of changes in utilization and outcomes in mechanical ventilation in COVID-19
This article has 12 authors:Reviewed by ScreenIT
-
Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model
This article has 6 authors:Reviewed by ScreenIT
-
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis
This article has 9 authors:Reviewed by ScreenIT
-
Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient
This article has 32 authors:Reviewed by ScreenIT
-
Building Back Better after COVID-19: a systematic scoping review of wicked problems affecting developed countries and implications for global governance
This article has 2 authors:Reviewed by ScreenIT
-
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
This article has 30 authors:Reviewed by ScreenIT
-
The relationship between new PCR positive cases and going out in public during the COVID-19 epidemic in Japan
This article has 7 authors:Reviewed by ScreenIT
-
Lessons Learned From the Resilience of Chinese Hospitals to the COVID-19 Pandemic: Scoping Review
This article has 6 authors:Reviewed by ScreenIT
-
Targeting the Microbiome With KB109 in Outpatients with Mild to Moderate COVID-19 Reduced Medically Attended Acute Care Visits and Improved Symptom Duration in Patients With Comorbidities
This article has 6 authors:Reviewed by ScreenIT